Updated 04:19 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,873.60 -0.33% CL 88.49 -0.08% BTC 64,896.46 +1.20%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,874 −0.33% BTC $64,896 +1.20% VIX 19.30 +3.21% latest tape · as of 04:19 UTC
The Screen · Real Estate · REIT - Diversified

JBG SMITH Properties

JBGS · the NYSE · USD · Market cap $653M · 596 employees

JBG SMITH Properties owns, operates, and develops mixed-use properties concentrated in amenity-rich, Metro-served submarkets.

FAIL · Does not pass the screen
12.54 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price12.54 USD at the 13 Nov 2026 close
  • Our value readFair vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.00)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available, base estimate $13.00 (screen dated 2026-11-13).

Current read
Markup ?
Fair · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.00, read 2026-11-14
  • Ethical does not pass the values gate
Price12.54 USD
Fair value13.00
Ethical score70.0/100
Value readFairas of 13 Nov 2026
Our investment reviews on this name
2026-10-23Read Markup11.15+12.5% to today ✓Accumulation gives way to Markup
2026-10-16Read Accumulation11.15+12.5% to today ✓Markdown gives way to Accumulation while volume is distributing
2026-10-02Read Markdown11.21+11.9% to today Distribution gives way to Markdown first Markdown read since August
2026-09-02Read Distribution11.80+6.3% to today Markdown gives way to Distribution after a 21% slide in 4 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

JBG SMITH Properties holds its Markup at $12.54. Consolidating, no directional conviction, held for 2 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 2 days
Price at the screen$12.54
ValuationN/A trailing · -7.20 forward price to earnings
Values screenFAIL · score 70.0
Beta1.06
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 57.96% Below 33% Interest-bearing debt is 58.0% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.70% Below 33% Cash held in interest-bearing accounts and securities is 0.7% of assets, under the one-third limit. Pass
Receivables 6.33% Below 49% Money owed to the company is 6.3% of assets, under the 49% limit. Pass
Revenue purity 0.84% Below 5% Only 0.8% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

JBG SMITH Properties's business is in a permissible area, but its interest-bearing debt is about 58% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when JBGS's ethical verdict changes

Today JBGS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Fair vs our fair value, as of 13 Nov 2026: it trades at roughly a 4% discount to our $13.00 fair value, 1.00% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

13.00Conservative13.00Base case13.00Growth case 12.54Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 3.5% discount to the base estimate.

Reading the gap · Our model sees value the Street hasn't fully caught up to yet.

Price History & Projections

Where our models see it going: fair-value estimate $13.00, range not available, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

DC Mixed Use Assets Face Persistent Losses

Picture a landlord in the capital's busiest corridors trying to fill offices and apartments while costs keep climbing. JBG SMITH owns and develops those mixed use sites around National Landing yet still posts a negative 22% profit margin and negative 8% return on equity. With revenue up only 6% and a forward multiple of negative 9.1 times, the business is not covering its cost of capital.

The shares sit at 14.88 dollars against a fair value of 15 dollars, giving almost no margin of safety. Two analysts see the same picture and offer no consensus rating. The ethical screen clears, yet the operating record shows consistent losses rather than the steady cash flows a REIT investor would expect.

Real estate cycles can turn quickly and any slowdown in Washington demand would widen those losses further. Thin pricing power and unknown competitive protection leave little room for error. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E-7.2x
EPS, trailing-2.56
EPS, forward-1.64
Revenue growth+1.0%slow but positive growth
Profit margin-30.0%currently unprofitable
Return on equity-10.9%not currently earning a positive return on equity
FCF yield27.38%
Dividend yield4.74%
Debt to equity1.64a meaningful debt load worth watching
Current ratio1.15adequate liquidity, worth monitoring
Beta1.06moves a little more than the market
Short interest, float0.26%
52-week range10.77 - 24.30
Market cap$653M
Employees596

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

JBGS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-09 Markup $12.44 +0.0% Entry 21

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (2 analysts) rates it underperform, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-08 Markup $12.44 +0.0% Entry 20

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (2 analysts) rates it underperform, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-07 Markup $12.44 -0.1% Entry 19

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (2 analysts) rates it underperform, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-06 Markup $12.45 +1.3% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (2 analysts) rates it underperform, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-05 Markup $12.29 +3.5% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 3.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (2 analysts) rates it underperform, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-03 Markup $11.88 +0.0% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (2 analysts) rates it underperform, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-02 Markup $11.88 +0.0% Entry 15

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (2 analysts) rates it underperform, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-01 Markup $11.88 +2.7% Entry 14

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (2 analysts) rates it underperform, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-31 Markup $11.57 +0.0% Entry 13

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (2 analysts) rates it underperform, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-30 Markup $11.57 +0.0% Entry 12

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (2 analysts) rates it underperform, with a mean price target of $14. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in JBGS's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $15.10 -2.0% $0.18 $991 -0.9%
2 months $14.44 +2.4% $0.18 $1,036 +3.6%
3 months $14.42 +2.5% $0.18 $1,037 +3.7%
6 months $17.14 -13.7% $0.35 $883 -11.7%
1 year $17.30 -14.5% $0.70 $895 -10.5%
2 years $13.22 +11.9% $1.40 $1,225 +22.5%
3 years $13.14 +12.6% $2.43 $1,310 +31.0%
5 years $28.10 -47.4% $4.00 $669 -33.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever JBGS does next, these words stay.

JBG SMITH Properties · JBGS · Markup · $12.54
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.